SPONSOR
Centre Leon Berard
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: GliomaCNS Tumor, AdultCNS Tumor, ChildhoodMalignant Solid NeoplasmsPapillary Renal Cell Carcinoma Type 2
Centre Leon Berard is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Glioma, CNS Tumor, Adult, CNS Tumor, Childhood, Malignant Solid Neoplasms.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Leon Berard
How many clinical trials has Centre Leon Berard sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Centre Leon Berard, of which 3 are actively recruiting participants. These trials cover conditions including Glioma, CNS Tumor, Adult, CNS Tumor, Childhood. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Leon Berard research focus on?
Centre Leon Berard clinical trials span Glioma, CNS Tumor, Adult, CNS Tumor, Childhood, Malignant Solid Neoplasms, Papillary Renal Cell Carcinoma Type 2. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre Leon Berard clinical trial?
To participate in a Centre Leon Berard trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Leon Berard trials with current recruitment status updated daily.
Clinical Trials by Centre Leon Berard
NCT07243470 Phase 1, Phase 2
Recruiting
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Glioma
NCT02029001 Phase 2
Recruiting
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
Malignant Solid Neoplasms
NCT05096390 Phase 2
Recruiting
Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC
Papillary Renal Cell Carcinoma Type 2
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology